Non-Alcoholic Steatohepatitis: Effect of Roux-en-Y Gastric Bypass Surgery
- 1 February 2006
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in The American Journal of Gastroenterology
- Vol. 101 (2), 368-373
- https://doi.org/10.1111/j.1572-0241.2006.00419.x
Abstract
Non-alcoholic steatohepatitis (NASH) is an increasingly prevalent problem. Treatment options are still under investigation. The primary aim of the study was to determine whether weight loss, achieved through Roux-en-Y gastric bypass (RYGBP), improved histopathology in obese patients with biopsy proven NASH. One hundred and forty-nine patients were identified from a surgical database as having RYGBP for obesity and concomitant intra-operative liver biopsies from October 2001 to September 2003. Thirty-five patients were found to have evidence of NASH at the time of surgery. Nineteen patients were contacted and underwent repeat percutaneous liver biopsies. Biopsies were evaluated and compared in blinded fashion by an experienced hepatopathologist. Fasting lipid panel, insulin and glucose, hemoglobin A1c (HgbA1c), and liver enzymes were obtained. Significant differences were noted in the following variables pre- and post-bypass surgery: body mass index 46.8–28.8 kg/m2 (p < 0.001); body weight in kilograms 132.1–79.7 (p < 0.001); glucose 102.9–94.1 mg/dL (p= 0.015); Hgb A1c 5.79–5.15% (p= 0.026); high density lipoprotein 45.7–64.4 mg/dL (p < 0.001); low density lipoprotein 112–88.6 mg/dL (p= 0.003); triglycerides 132.1–97 mg/dL (p= 0.013). Significant improvements in steatosis, lobular inflammation, portal, and lobular fibrosis were noted. Histopathologic criteria for NASH were no longer found in 17/19 patients (89%). Weight loss after gastric bypass surgery in obese patients with NASH results in significant improvement in glucose, HgbA1c. and lipid profiles. Furthermore, RYGBP results in significant improvement in the histological features of NASH with resolution of disease in a majority of these patients.Keywords
This publication has 17 references indexed in Scilit:
- A pilot study of orlistat treatment in obese, non‐alcoholic steatohepatitis patientsAlimentary Pharmacology & Therapeutics, 2004
- Advances in the Understanding and Treatment of Nonalcoholic Fatty Liver DiseaseDrugs, 2003
- Prevalence and Trends in Obesity Among US Adults, 1999-2000Jama-Journal Of The American Medical Association, 2002
- Treatment of obesity: need to focus on high risk abdominally obese patientsBMJ, 2001
- Liver abnormalities in severely obese subjects: Effect of drastic weight loss after gastroplastyInternational Journal of Obesity, 1998
- Therapeutic effects of restricted diet and exercise in obese patients with fatty liverJournal of Hepatology, 1997
- Hepatic effects of dietary weight loss in morbidly obese subjectsJournal of Hepatology, 1991
- Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factorsHepatology, 1990
- Effect of weight reduction on hepatic abnormalities in overweight patientsGastroenterology, 1990
- Effect on Hepatic Morphology of Treatment of Obesity by Fasting, Reducing Diets and Small-Bowel BypassThe New England Journal of Medicine, 1970